Skip to content

Text Size: AAA

INVESTORS

Printer Friendly Version Print  |  E-mail this page Email  |  E-mail Alerts Alerts  |  RSS RSS  |  View contacts Contacts  |  Download Financial Tear Sheet Tear Sheet

Webcast ImageWebcast
Amylin Pharmaceuticals, Inc. at JPMorgan Healthcare Conference (Replay)
01/11/10 at 3:30 p.m. PT
Webcast ImageWebcast
Q4 2009 Amylin Pharmaceuticals, Inc. Earnings Conference Call (Replay)
01/27/10 at 5:00 p.m. ET
Our Investor Relations Center is provided to give you convenient access to company information, including financial reports, press releases and corporate events. You can also sign up to be reminded via email of any upcoming company presentations, or to be notified of news releases and other announcements.

If you cannot find the information you're looking for on our website please let us know, and we will do our best to accommodate your request.
FEATURED REPORT
Download Documentation 2008 Form 10K
RECEIVE E-MAIL ALERTS
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
STOCK QUOTE
AMLN (Common)
ExchangeNASDAQ (US Dollar)
Price$17.33
Change (%) Stock is Up 0.17 (0.99%)
Volume2,227,697
Data as of 02/08/10 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
RECENT NEWSMore
DateTitle 
01/27/10Amylin Pharmaceuticals Reports 2009 Financial Results
2009 Non-GAAP Operating Loss Improves by 57% Over 2008SAN DIEGO, Jan. 27, 2010 /PRNewswire via COMTEX/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today reported financial results for the quarter and year ended December 31, 2009. The Company reported total revenue of $758.4 million for the year ended December 31, 2009, which includes net product sales of $754.0 million. Non-GAAP operating loss was $58.7 million for the year, compared to $137.2 million for 2008. Net loss excluding restructuri... 
Printer Friendly Version
01/20/10Amylin Pharmaceuticals to Webcast Year-End Financial Results
SAN DIEGO, Jan. 20, 2010 /PRNewswire via COMTEX/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its Quarterly Update Conference Call for the fourth quarter and full year 2009 on Wednesday, January 27, 2010 at 5:00 p.m. ET/2:00 p.m. PT. Daniel M. Bradbury, Amylin's president and chief executive officer, will lead the call. On the same date post-market, Amylin will release financial results for the fourth quarter and year ended December 31, 2009. The call will be webcast live throug... 
Printer Friendly Version
01/11/10Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
SAN FRANCISCO, Jan. 11, 2010 /PRNewswire via COMTEX/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced the 2010 corporate priorities that will position the Company to address the dual epidemics of diabetes and obesity, achieve positive operating cash flow by the end of the year and place the Company on the path to operating profitability by the end of 2011. The news was presented by Daniel M. Bradbury, president and chief executive officer, at the 28th Annual J.P. Morgan Healthcare... 
Printer Friendly Version
01/04/10Amylin Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
SAN DIEGO, Jan 04, 2010 /PRNewswire-FirstCall via COMTEX/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the J.P. Morgan Healthcare Conference in San Francisco on Monday, January 11, 2010 at 6:30 p.m. ET / 3:30 p.m. PT. Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview. The live presentation and break-out session will be webcast, and a recording will be made available following the event. The webcast and ... 
Printer Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.